Delisting riskEarnings in 3d
BioRestorative Therapies
Develops autologous cell therapies and cell-secretome cosmetics for spine and metabolic applications.
$0.2001
After-hours close0.00 (0.00%)
At close$0.2001(−2.86%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 2.66%677.1K sharesInsiders 0.74%187.5K sharesOther 96.60%24.61M shares
Shares outstanding 25.48M · Float 23.76M · 93.3% free float
Institutions13F, as of Mar 31, 2026
10 holders · 677.1K shares · 2 new positions · 6 increased · 0 reduced · 5 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Citadel Advisors LLC | 238.6K | 0.94% | +209.4K | May 15, 2026 |
| Geode Capital Management, LLC | 223.1K | 0.88% | +165.2K | May 15, 2026 |
| UBS Group AG | 99.8K | 0.39% | +99.8Knew | May 5, 2026 |
| Wealth Alliance | 40.0K | 0.16% | 0 | May 14, 2026 |
| Vanguard Fiduciary Trust Co | 39.5K | 0.15% | +39.5Knew | May 8, 2026 |
| State Street Corp | 32.5K | 0.13% | 0 | May 15, 2026 |
| Advisor Group Holdings, Inc. | 2.0K | 0.01% | 0 | May 15, 2026 |
| Tower Research Capital LLC (TRC) | 1.5K | 0.01% | +356 | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Alstodt Lance | 15.50% | 1.24M | 13D | Feb 19, 2025 ↗ |
| Silva, Francisco | 15.10% | 1.20M | 13D | Feb 19, 2025 ↗ |
| Auctus Fund, LLC | 9.90% | 2.70M | 13G | May 15, 2026 ↗ |
| Auctus Fund Management LLC | 9.90% | 759.1K | 13G | May 15, 2025 ↗ |
| Alta Partners LLC | 7.70% | 1.79M | 13G | Feb 13, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Lance Alstodt | director, 10 percent owner, officer: President, CEO, COB | 187.5K | 0.74% | Oct 20, 2025 |
4 ten-percent owners hold 446.2K shares by Form 4, outside the officers-and-directors figure above · 11 people have not refiled in the last 18 months (164.0K shares), so they are not in the figure above
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.
